Johnson SB et al., 2018-10-01: Companion NCDB study of 1,901,815 patients: complementary medicine users were far more likely to refuse surgery, chemotherapy, radiotherapy or hormone therapy, and had higher mortality – but the survival association disappeared once refusal or delay was included in the model.
However, there was no significant association between CM and survival once treatment delay or refusal was included in the model (hazard ratio, 1.39; 95% CI, 0.83-2.33).
p.1375 (Abstract, Results)
Johnson SB et al., 2018-10-01: Companion NCDB study of 1,901,815 patients: complementary medicine users were far more likely to refuse surgery, chemotherapy, radiotherapy or hormone therapy, and had higher mortality – but the survival association disappeared once refusal or delay was included in the model. Conflicts (MEDLINE, truncated): Dr Park reports honoraria from Varian Medical Systems; remaining disclosures are cut off in the record. Comparator: no complementary medicine, matched on stage, comorbidity, insurance, race and year. The mediation result is the most important line for an honest reading: the excess mortality tracked refusal of conventional treatment, not the use of complementary medicine alongside it. Study type: controlled study.
